Publications

Conference Abstract

Differentiation of Adults with Type 1 Versus Type 2 Diabetes in Administrative Claims Analysis: Experience from the Biologics and Biosimilars Collective Intelligence Consortium

Academy of Managed Care Pharmacy Nexus 2018

October 25, 2018

Authors:

McMahill-Walraven C, Kent D, Marshall J, Lockhart CM, and the BBCIC Insulin Research Team

Expertise:

RWE Research & Consulting

Conference Abstract

Development and Management of a Distributed Research Network for Evaluating Real-World Outcomes for Biologics and Their Biosimilars

Academy of Managed Care Pharmacy Nexus 2018

October 25, 2018

Authors:

Mendelsohn AB, Barr CE, Brown J, Cziraky M, King K, Lin N, Lockhart CM, Pawloski PA, Eichelberger B

Expertise:

RWE Research & Consulting

Publication

Do FDA Label Changes Work? Assessment of the 2010 Class Label Change for Proton Pump Inhibitors Using the Sentinel System's Analytic Tools

Pharmacoepidemiology & Drug Safety

February 2, 2018

Authors:

Sobel RE, Bate A, Marshall J, Haynes K, Selvam N, Nair V, Daniel G, Brown JS, Reynolds RF

Expertise:

RWE Research & Consulting

Conference Abstract

Safety of Trumenba Vaccine Among Pregnant Women in the United States: Planning and Design of a Large-Scale Multi-Site Observational Study

33th Annual International Society for Pharmacoepidemiology Conference

August 22, 2017

Authors:

Panozzo CA, Purcell B, Andrade S, Griffin MR, Haynes K, Lin ND, McMahill-Walraven CN, Naleway A, Young J, Brown JS, Stark J

Capabilities:

Pregnancy & Mother-Infant Linked Studies

Multi-Site Methods & Coordination

Expertise:

Regulatory Research & Support

RWE Research & Consulting

Conference Abstract

Oral Contraceptives and VTE Across the Sentinel Data Network-An IMEDS Evaluation Pilot Assessment

32th Annual International Society for Pharmacoepidemiology Conference

August 24, 2016

Authors:

Bate A, Sobel R, Marshall J, Daniel G, McCall T, Reynolds R, Brown J

Expertise:

RWE Research & Consulting

Publication

A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance

Drug Safety

June 9, 2015

Authors:

Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A

Expertise:

RWE Research & Consulting

Publication

Utilizing Data Consortia to Monitor Safety and Effectiveness of Biosimilars and Their Innovator Products

Journal of Managed Care & Specialty Pharmacy

January 21, 2015

Authors:

AMCP Task Force on Biosimilar Collective Intelligence Systems; Baldziki M, Brown J, Chan H, Cheetham TC, Conn T, Daniel GW, Hendrickson M, Hilbrich L, Johnson A, Miller SB, Moore T, Motheral B, Priddy SA, Raebel MA, Randhawa G, Surratt P, Walraven C, White TJ, Bruns K, Carden MJ, Dragovich C, Eichelberger B, Rosato E, Sega T

Expertise:

RWE Research & Consulting

Publication

Four Health Data Networks Illustrate the Potential for a Shared National Multipurpose Big-Data Network

Health Affairs

July 1, 2014

Authors:

Curtis LH, Brown J, Platt R

Expertise:

RWE Research & Consulting